The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Kura Sushi USA, Inc. (NASDAQ:KRUS) Q2 2025 Earnings Call Transcript April 8, 2025 Kura Sushi USA, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were $-0.08.

Kura Sushi (NASDAQ:KRUS) slipped in early trading on Wednesday after the restaurant company reported an in-line FQ2 earnings report. Revenue increased 13.3% year-over-year to $64.9 million for the ...

The Kenya Urban Roads Authority (KURA) came under pressure from the National Assembly's Public Investments Committee on Commercial Affairs and Energy after lawmakers raised concerns over delays in ...

Kura Sushi USA continues to focus on expanding its market presence and enhancing operational efficiency through technological innovations like a new reservation system and streamlined in-store ...

Submission seeks approval for the treatment of adult patients with relapsed or refractory AML with a NPM1 mutation – SAN DIEGO and TOKYO, April 08, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq ...

Kura Sushi USA Inc. reported its earnings for the second quarter of fiscal year 2025, revealing a wider-than-expected loss per share but a positive aftermarket stock reaction. The company posted ...

Sushi restaurant chain Kura Sushi (NASDAQ:KRUS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 13.3% year on year to $64.89 million. On the other hand, the company’s full ...

Kura and Kyowa Kirin are conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-m and KMT2A-rearranged AML.

SAN DIEGO and TOKYO, April 08, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA, “Kura”), and Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin ...